Overview Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets Status: Completed Trial end date: 2011-05-01 Target enrollment: Participant gender: Summary To monitor use in real practice including safety and efficacy of Champix tablets 0.5mg, 1mg medication for 12 weeks in smokers Details Lead Sponsor: PfizerTreatments: Varenicline